The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Polypharmacology: drug discovery for the future
Open accessAbstract
In recent years, even with remarkable scientific advancements and a significant increase of global research and development spending, drugs are frequently withdrawn from markets. This is primarily due to their side effects or toxicities. Drug molecules often interact with multiple targets, coined as polypharmacology, and the unintended drug-target interactions could cause side effects. Polypharmacology remains one of the major challenges in drug development, and it opens novel avenues to rationally design the next generation of more effective, but less toxic, therapeutic agents. This review outlines the latest progress and challenges in polypharmacology studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Predicting new molecular targets for rhein using network pharmacology
Zhang, A., Sun, H. J., Yang, B., & Wang, X. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-20 · Cited by 47
RetractedBerman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
Database resources of the National Center for Biotechnology Information: update
Wheeler, D. L. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh073 · Cited by 10,641
Network biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903
KEGG for integration and interpretation of large-scale molecular data sets
Kanehisa, M., Goto, S., Sato, Y., Furumichi, M., & Tanabe, M. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr988 · Cited by 4,848
Network pharmacology: the next paradigm in drug discovery
Hopkins, A. L. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.118 · Cited by 4,622
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
ZINC − A Free Database of Commercially Available Compounds for Virtual Screening
Irwin, J. J., & Shoichet, B. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049714+ · Cited by 4,058
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
Relating protein pharmacology by ligand chemistry
Keiser, M. J., Roth, B. L., Armbruster, B. N., Ernsberger, P., Irwin, J. J., & Shoichet, B. K. (2007) · Nature Biotechnology · doi:10.1038/nbt1284 · Cited by 2,402
BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities
Liu, T., Lin, Y., Wen, X., Jorissen, R. N., & Gilson, M. K. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl999 · Cited by 2,124
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
Knox, C., Law, V., Jewison, T., Liu, P., Ly, S., Frolkis, A., Pon, A., Banco, K., Mak, C., Neveu, V., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1126 · Cited by 1,831
Yıldırım, M. A., Goh, K.-I., Cusick, M. E., Barabási, A.-L., & Vidal, M. (2007) · Nature Biotechnology · doi:10.1038/nbt1338 · Cited by 1,708
Drug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248
Hopkins, A. L. (2007) · Nature Biotechnology · doi:10.1038/nbt1007-1110 · Cited by 1,242
Prediction of drug–target interaction networks from the integration of chemical and genomic spaces
Yamanishi, Y., Araki, M., Gutteridge, A., Honda, W., & Kanehisa, M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn162 · Cited by 1,147
Database resources of the National Center for Biotechnology Information
Wheeler, D. L., Barrett, T., Benson, D. A., Bryant, S. H., Canese, K., Chetvernin, V., Church, D. M., DiCuccio, M., Edgar, R., Federhen, S., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1000 · Cited by 1,007
Navigating chemical space for biology and medicine
Lipinski, C., & Hopkins, A. (2004) · Nature · doi:10.1038/nature03193 · Cited by 1,002
STITCH: interaction networks of chemicals and proteins
Kuhn, M., von Mering, C., Campillos, M., Jensen, L. J., & Bork, P. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm795 · Cited by 998
Chong, C. R., & Sullivan, D. J. (2007) · Nature · doi:10.1038/448645a · Cited by 983
Large-scale prediction and testing of drug activity on side-effect targets
Lounkine, E., Keiser, M. J., Whitebread, S., Mikhailov, D., Hamon, J., Jenkins, J. L., Lavan, P., Weber, E., Doak, A. K., Côté, S., et al. (2012) · Nature · doi:10.1038/nature11159 · Cited by 881
Global mapping of pharmacological space
Paolini, G. V., Shapland, R. H. B., van Hoorn, W. P., Mason, J. S., & Hopkins, A. L. (2006) · Nature Biotechnology · doi:10.1038/nbt1228 · Cited by 811
The model organism as a system: integrating 'omics' data sets
Joyce, A. R., & Palsson, B. Ø. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1857 · Cited by 785
Wang, Y., Xiao, J., Suzek, T. O., Zhang, J., Wang, J., Zhou, Z., Han, L., Karapetyan, K., Dracheva, S., Shoemaker, B. A., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1132 · Cited by 659
Functional and topological characterization of protein interaction networks
Yook, S., Oltvai, Z. N., & Barabási, A. (2004) · PROTEOMICS · doi:10.1002/pmic.200300636 · Cited by 613
Structure-Based Virtual Screening for Drug Discovery: a Problem-Centric Review
Cheng, T., Li, Q., Zhou, Z., Wang, Y., & Bryant, S. H. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9322-0 · Cited by 574
Key factors in the rising cost of new drug discovery and development
Dickson, M., & Gagnon, J. P. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1382 · Cited by 498
Risks in new drug development: Approval success rates for investigational drugs
DiMasi, J. A. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.115446 · Cited by 450
Durongpisitkul, K., Gururaj, V. J., Park, J. M., & Martin, C. F. (1995) · PEDIATRICS · doi:10.1542/peds.96.6.1057 · Cited by 443
Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases
Apsel, B., Blair, J. A., Gonzalez, B., Nazif, T. M., Feldman, M. E., Aizenstein, B., Hoffman, R., Williams, R. L., Shokat, K. M., & Knight, Z. A. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.117 · Cited by 440
Knockouts model the 100 best-selling drugs—will they model the next 100?
Zambrowicz, B. P., & Sands, A. T. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd987 · Cited by 393
Systems Pharmacology: Network Analysis to Identify Multiscale Mechanisms of Drug Action
Zhao, S., & Iyengar, R. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134520 · Cited by 358
Chen, Y. Z., & Zhi, D. G. (2001) · Proteins: Structure, Function, and Genetics · doi:10.1002/1097-0134(20010501)43:2<217::aid-prot1032>3.0.co;2-g · Cited by 353
Nidhi, Glick, M., Davies, J. W., & Jenkins, J. L. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci060003g · Cited by 340
Chemical genetic discovery of targets and anti-targets for cancer polypharmacology
Dar, A. C., Das, T. K., Shokat, K. M., & Cagan, R. L. (2012) · Nature · doi:10.1038/nature11127 · Cited by 333
Irreversible Protein Kinase Inhibitors: Balancing the Benefits and Risks
Barf, T., & Kaptein, A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3003203 · Cited by 331
Drug repurposing: far beyond new targets for old drugs
Oprea, T. I., & Mestres, J. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9390-1 · Cited by 285
Systems approaches to polypharmacology and drug discovery.
Boran, A. D. W., & Iyengar, R. (2010) · PubMed · Cited by 257
The Comparative Toxicogenomics Database: update 2011
Davis, A. P., King, B. L., Mockus, S., Murphy, C. G., Saraceni-Richards, C., Rosenstein, M., Wiegers, T., & Mattingly, C. J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq813 · Cited by 235
Ligand Depot: a data warehouse for ligands bound to macromolecules
Feng, Z., Chen, L., Maddula, H., Akcan, O., Oughtred, R., Berman, H. M., & Westbrook, J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth214 · Cited by 215
SuperTarget goes quantitative: update on drug-target interactions
Hecker, N., Ahmed, J., von Eichborn, J., Dunkel, M., Macha, K., Eckert, A., Gilson, M. K., Bourne, P. E., & Preissner, R. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr912 · Cited by 213
Knowledge discovery by automated identification and ranking of implicit relationships
Wren, J. D., Bekeredjian, R., Stewart, J. A., Shohet, R. V., & Garner, H. R. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg421 · Cited by 210
Xie, L., Xie, L., Kinnings, S. L., & Bourne, P. E. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134630 · Cited by 202
Docking and chemoinformatic screens for new ligands and targets
Kolb, P., Ferreira, R. S., Irwin, J. J., & Shoichet, B. K. (2009) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2009.08.003 · Cited by 193
Binding MOAD, a high-quality protein ligand database
Benson, M. L., Smith, R. D., Khazanov, N. A., Dimcheff, B., Beaver, J., Dresslar, P., Nerothin, J., & Carlson, H. A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm911 · Cited by 178
Hopkins, A. L. (2009) · Nature · doi:10.1038/462167a · Cited by 176
Sannella, A. R., Casini, A., Gabbiani, C., Messori, L., Bilia, A. R., Vincieri, F. F., Majori, G., & Severini, C. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.02.028 · Cited by 172
Text mining for the biocuration workflow
Hirschman, L., Burns, G. A. P. C., Krallinger, M., Arighi, C., Cohen, K. B., Valencia, A., Wu, C. H., Chatr-Aryamontri, A., Dowell, K. G., Huala, E., et al. (2012) · Database · doi:10.1093/database/bas020 · Cited by 168
Wiegers, T. C., Davis, A. P., Cohen, K. B., Hirschman, L., & Mattingly, C. J. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-326 · Cited by 144
JChem: Java Applets and Modules Supporting Chemical Database Handling from Web Browsers
Csizmadia, F. (2000) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci9902696 · Cited by 122
WOMBAT: World of Molecular Bioactivity
Olah, M., Mracec, M., Halip, L., Rad-Curpăn, R., Bora, A., Hadaruga, N. G., Olah, I., Banda, M., Simon, Z., Mracec, M., et al. (2005) · Methods and principles in medicinal chemistry · doi:10.1002/3527603743.ch9 · Cited by 117
Oprea, T. I., Nielsen, S. K., Ursu, O., Yang, J. J., Taboureau, O., Mathias, S. L., Kouskoumvekaki, I. A., Sklar, L. A., & Bologa, C. (2011) · Molecular Informatics · doi:10.1002/minf.201100023 · Cited by 115
NCATS launches drug repurposing program
Allison, M. (2012) · Nature Biotechnology · doi:10.1038/nbt0712-571a · Cited by 113
IUPHAR-DB: new receptors and tools for easy searching and visualization of pharmacological data
Sharman, J. L., Mpamhanga, C. P., Spedding, M., Germain, P., Staels, B., Dacquet, C., Laudet, V., Harmar, A. J., & NC-IUPHAR (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1062 · Cited by 106
Prediction of Chemical-Protein Interactions Network with Weighted Network-Based Inference Method
Cheng, F., Zhou, Y., Li, W., Liu, G., & Tang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041064 · Cited by 101
DeBusk, R. F., Pepine, C. J., Glasser, D. B., Shpilsky, A., Deriesthal, H., & Sweeney, M. L. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.09.030 · Cited by 99
Exploring Polypharmacology Using a ROCS-Based Target Fishing Approach
AbdulHameed, M. D. M., Chaudhury, S., Singh, N. P., Sun, H., Wallqvist, A., & Tawa, G. J. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci2003544 · Cited by 84
Baumann, K., du Bois, A., Meier, W., Rau, J., Wimberger, P., Sehouli, J., Kurzeder, C., Hilpert, F., Hasenburg, A., Canzler, U., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds003 · Cited by 84
Computational Tools for Polypharmacology and Repurposing
Achenbach, J., Tiikkainen, P., Franke, L., & Proschak, E. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.62 · Cited by 78
An inverse docking approach for identifying new potential anti-cancer targets
Grinter, S. Z., Liang, Y., Huang, S., Hyder, S. M., & Zou, X. (2011) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2011.01.002 · Cited by 77
Durrant, J. D., Amaro, R. E., Xie, L., Urbaniak, M. D., Ferguson, M. A. J., Haapalainen, A. M., Chen, Z., Guilmi, A. M. D., Wunder, F., Bourne, P. E., et al. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000648 · Cited by 77
Davis, A. P., Murphy, C. G., Rosenstein, M. C., Wiegers, T. C., & Mattingly, C. J. (2008) · BMC Medical Genomics · doi:10.1186/1755-8794-1-48 · Cited by 76
Integrating text mining into the MGI biocuration workflow
Dowell, K. G., McAndrews-Hill, M., Hill, D. P., Drabkin, H., & Blake, J. A. (2009) · Database · doi:10.1093/database/bap019 · Cited by 75
Ulahannan, S. V., & Brahmer, J. R. (2011) · Cancer Investigation · doi:10.3109/07357907.2011.554476 · Cited by 69
Vazquez-Martin, A., López-Bonetc, E., Cufí, S., Oliveras-Ferraros, C., Del Barco, S., Martin-Castillo, B., & Menendez, J. A. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.04.003 · Cited by 66
Chen, D., & Dou, Q. P. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.6.739 · Cited by 66
Drug Effect Prediction by Polypharmacology-Based Interaction Profiling
Simon, Z., Peragovics, Á., Vigh-Smeller, M., Csukly, G., Tombor, L., Yang, Z., Zahoránszky-Köhalmi, G., Végner, L., Jelinek, B., Hári, P., et al. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci2002022 · Cited by 65
Evaluation of various inverse docking schemes in multiple targets identification
Liu, H., Shen, Q., Zhang, J., & Fu, W. (2010) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2010.09.004 · Cited by 55
Molecular Networks in Drug Discovery
Morrow, J. K., Tian, L., & Zhang, S. (2010) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.v38.i2.30 · Cited by 54
Self-citationBoran, A. D. W., & Iyengar, R. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20191 · Cited by 51
Berman, J., Haffajee, C. I., & Alpert, J. S. (1981) · American Heart Journal · doi:10.1016/0002-8703(81)90610-4 · Cited by 49
New Uses for Old Drugs in HIV Infection: The Role of Hydroxyurea, Cyclosporin and Thalidomide
Ravot, E., Lisziewicz, J., & Lori, F. (1999) · Drugs · doi:10.2165/00003495-199958060-00001 · Cited by 39
Cross-Pharmacology Analysis of G Protein-Coupled Receptors
Briansó, F., Carrascosa, M. C., Oprea, T. I., & Mestres, J. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611796391285 · Cited by 38
A Mapping of Drug Space from the Viewpoint of Small Molecule Metabolism
Adams, J. C., Keiser, M. J., Basuino, L., Chambers, H. F. “., Lee, D., Wiest, O., & Babbitt, P. C. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000474 · Cited by 36
Krallinger, M., Leitner, F., Vázquez, M., Salgado, D., Marcelle, C., Tyers, M., Valencia, A., & Chatr‐aryamontri, A. (2012) · Database · doi:10.1093/database/bas017 · Cited by 32
Hypothesis-driven omics integration
Schmid, A., & Blank, L. M. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.398 · Cited by 23
Aspirin and Cancer: Trials and Observational Studies
Baron, J. A. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs338 · Cited by 15
Dosing Frequency of Aspirin and Prevention of Heart Attacks and Strokes
Amory, J. K., & Amory, D. W. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.04.023 · Cited by 10
Mapping drug-target interaction networks
Tian, L., & Zhang, S. (2009) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2009.5335053 · Cited by 7
Self-citationThe Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer
Konopa, K., & Jassem, J. (2009) · Current Drug Targets · doi:10.2174/138945010790030965 · Cited by 6
Mr, S., Nr, S., & Hc, M. (1966) · PubMed · Cited by 4
Cited by
Artificial intelligence in drug discovery and development
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695
Towards the sustainable discovery and development of new antibiotics
Miethke, M., Pieroni, M., Weber, T., Brönstrup, M., Hammann, P., Halby, L., Arimondo, P. B., Glaser, P., Aigle, B., Bode, H. B., et al. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00313-1 · Cited by 1,151
Polypharmacology: Challenges and Opportunities in Drug Discovery: Miniperspective
Anighoro, A., Bajorath, J., & Rastelli, G. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5006463 · Cited by 1,131
Artificial intelligence in drug development: Present status and future prospects
Mak, K.-K., & Pichika, M. R. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.014 · Cited by 1,018
Drug repurposing: a promising tool to accelerate the drug discovery process
Parvathaneni, V., Kulkarni, N. S., Muth, A., & Gupta, V. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.06.014 · Cited by 597
Metadata
- Authors
- Reddy, A. S., & Zhang, S.
- Venue
- Expert Review of Clinical Pharmacology
- Publisher
- Informa UK Limited
- Published
- 2013-01
- Volume
- 6
- Issue
- 1
- Pages
- 41-47
- ISSN
- 1751-2433 (ISSN-L)
- 1751-2441
- OpenAlex
- W2127587566
- Cited by
- 479
- References
- 82
- FWCI
- 15.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.